SEP 11, 2018 10:43 PM PDT

Stimuli-Responsive Nanoparticles as a Drug Delivery Method

WRITTEN BY: Nouran Amin

Image Credit: Phys.Org

Researchers at Washington State University (WSU), who were finding a way to fight an inflammatory response that causes organ failure better known as sepsis, show that stimuli-responsive nanoparticles can target infections to simultaneously inhibit the spread of bacteria and decrease inflammation. Such microscopic particles include abundant antibiotic and anti-inflammatory agents that are released when the particles encounter an infection in the body.

"This study not only proves a new drug delivery system but also may shift the current landscape in nanomedicine to a biology-driven design of nanotherapeutics. This has the potential to improve the therapies of many more infectious diseases," explains Zhenjia Wang, a pharmaceutical sciences professor.

The research study, published in the journal Advanced Materials, shows how WSU scientists developed a new nanoparticle that is coated with compounds that are commonly secreted by blood vessels in response to an infection. The nanoparticle is sensitive to infections sites allowing the bacterial enzymes to be triggered for the release of drugs.

Image Credit: Structure of a nanoparticle via Kaust.edu

Although with antibiotics and anti-inflammatories are used to mitigate the onset of sepsis, there remain issues with “old school use of these therapies”. "This study will allow chemists and materials engineers to design new drug formulations to treat many bacterial infections, such as TB infection," explains Can Yang Zhang, who is the leading author on the paper and a postdoctoral research associate in the Wang lab.

In medicine, nanoparticle technology is growing, however, it is a first time that a nanocarrier has been developed to deliver not one, but two drugs. Furthermore, nanocarrier specifically targets infection sites, so less medicine may be a needed to fix collateral damage to otherwise healthy tissues.

Source: Washington State University

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 15, 2019
Drug Discovery & Development
DEC 15, 2019
Compound in Daffodils Can Help Fight Cancer
Preventing the growth of tumors presents a challenge for scientists in finding a cure to cancer. Now however, researchers from the University Libre de Brux...
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
CBD Extract for Cannabis Addiction
Some people believe the secret to curing a hangover is to drink more alcohol the morning after a night of binge drinking - “the hair of the dog that...
DEC 15, 2019
Cancer
DEC 15, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
DEC 15, 2019
Drug Discovery & Development
DEC 15, 2019
Common Therapeutic Can Treat Bleeding Associated with Traumatic Brain Injury
An inexpensive and accessible drug was found to reduce rates of mortality associated with traumatic brain injury (TBI) patients by 20%. TBI is a major caus...
DEC 15, 2019
Neuroscience
DEC 15, 2019
First Drug to Slow Progression of Alzheimer's Shows Promise
An estimated 5.8 million people living in the US have Alzheimer’s disease. Currently, no cure is available and any drugs have only been able to treat...
DEC 15, 2019
Microbiology
DEC 15, 2019
Hybrid Antibiotic Can Destroy Dangerous Staph Biofilms
When staph begins to grow on medical devices like implants used on wounds, artificial joints, or catheters, they can cause chronic, serious infections....
Loading Comments...